Coronavirus Impacts on Industry – Part 2

Pandemic Slowing Other Aspects of Drug R&D   In our previous post, we discussed how the COVID-19 pandemic is spurring world-wide efforts to discover and develop new diagnostics, vaccines and treatments aimed at preventing infection or mitigating its most severe effects…. Read »

Coronavirus Impacts on Industry – Part 1

 The race to develop new tests, vaccines, and treatments   As the COVID-19 pandemic rages on, the effects of the virus are being felt not only by the global populace, but by the various sectors of the health care industry… Read »

Coronavirus Impacts on Patient Care – Part 2

Encouraging patients to avoid coming into the health care facility or hospital has been a boon for the uptake of telehealth services. There has been an unprecedented surge in demand for remote health care, with one U.S. provider, Teladoc, reporting… Read »

Coronavirus Impacts on Patient Care – Part 1

The COVID-19 pandemic has grabbed the world’s attention in recent weeks, and is likely to dominate the news, both generally and within the healthcare universe, for some time to come. COVID-19 is having broad and significant effects on health care,… Read »

Actions Around Drug Pricing Centering on Insulin

While injectable insulin has existed in some form for a century, the prices of some have tripled over the last 10 years. In part, this has been due to the introduction of branded, performance-enhanced and longer-lasting insulin analogs that offer… Read »

FDA Finalizes Gene Therapy Guidelines and Adds New Draft Guidance on Orphan Drug Exclusivity

Gene therapy has come a long way since 1972, when researchers publishing in the journal Science first suggested this approach might someday provide a means of treating genetic disorders. While research was held back for several years following a patient… Read »

New Research Findings — and Potential New Avenues for Drug Discovery — in Type 2 Diabetes

Many important basic discoveries about human biology have been made using “model organisms” — more primitive species with biological processes that have been carried down through evolution to humans. Recently, researchers at Vanderbilt University and the University of Michigan identified… Read »

Helping to Bring Precision Medicine to Community Oncology Practices

The use of precision medicine and targeted therapies in the treatment of cancer is quickly increasing. However, implementing such approaches in the community, where most patients are seen, often remains a challenge. Clinicians struggle to identify which molecular diagnostic tests… Read »

New Treatment Options for Hemoglobin-Based Blood Disorders

  Sickle cell disease is a group of inherited disorders that affects hemoglobin, the oxygen-carrying protein in red blood cells (RBCs), and causes these cells to distort in shape at low oxygen levels. This condition affects 1 in 500… Read »

New Treatments for Alzheimer’s Disease? Maybe.

The Alzheimer’s Association estimates that nearly six million Americans are living with the disease, a number that is expected to rise to 14 million by 2050. Marketed drugs such as memantine and donepezil modestly slow memory loss in some… Read »

1 2 3 20